ADSCs-EVs Carrying circITCH Inhibit Pyroptosis of Renal Tubular Epithelial Cells and Alleviate LPS-Induced Acute Kidney Injury.
Yang H., Liu Y., Hu J., Li X., Huo P.
Animal Study on Acute Kidney Injury, published in FASEB J (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- FASEB J (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41445440
- DOI
- 10.1096/fj.202502703R
Abstract (original English)
This study investigates the mechanism of adipose-derived stem cells-extracellular vesicles (ADSCs-EVs) carrying circITCH in lipopolysaccharides (LPS)-induced acute kidney injury (AKI). The effect of EVs on pyroptosis was validated in vitro and in vivo LPS-induced models. circITCH, RBM15, or CRBN expression was detected via RT-qPCR or western blot. The binding of circITCH to HuR or β-TrCP was analyzed by RIP or RNA pull down. The interaction between HuR, β-TrCP, and RBM15 was analyzed by Co-IP or RIP. After treatment with cycloheximide or MG132, HuR protein expression or ubiquitination level was detected by western blot. m6A modification and of IGF2BP1 enrichment on CRBN were analyzed by RIP. EVs treatment decreases Cre and BUN levels, reduces renal tubular injury score and injured renal tubules, and inhibits pyroptosis in renal tissues and cells. EVs carry circITCH into cells to upregulate circITCH expression in renal tissues and cells. Mechanistically, low expression of circITCH weakens the interaction between HuR and β-TrCP, reduces HuR ubiquitination, and enhances the interaction between HuR and RBM15 mRNA, thereby increasing m6A modification on CRBN and promoting CRBN expression in an IGF2BP1-dependent manner. Collectively, ADSCs-EVs alleviate renal tubular epithelial cell pyroptosis by carrying circITCH, ultimately reducing LPS-induced AKI.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024
Systematic Review on Chronic Kidney Disease, Acute Kidney Injury, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol2 citations - Level AMeta-analysisEurope PMC
Protective role of exosomes in renal ischemia-reperfusion injury: a systematic review and meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol1 citations - Level AMeta-analysisEurope PMC
Extracellular vesicles for ischemia/reperfusion injury-induced acute kidney injury: a systematic review and meta-analysis of data from animal models
Meta-analysis on Acute Kidney Injury, published in Syst Rev (2022) — summary generated from the PubMed abstract.
- 2022
Syst Rev8 citations - Level AMeta-analysisEurope PMC
Extracellular vesicles for acute kidney injury in preclinical rodent models: a meta-analysis
Meta-analysis with a reported sample of 552 on Acute Kidney Injury, Chronic Inflammation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
- n = 552
Stem Cell Res Ther35 citations - Level AMeta-analysisPubMed
Concise Review: Using Fat to Fight Disease: A Systematic Review of Nonhomologous Adipose-Derived Stromal/Stem Cell Therapies.
Meta-analysis on Osteoarthritis, Acute Kidney Injury, Cardiovascular Disease, Stroke Research, published in Stem Cells (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cells101 citations - Level AMeta-analysisEurope PMC
Extracellular vesicles derived from mesenchymal stromal cells may possess increased therapeutic potential for acute kidney injury compared with conditioned medium in rodent models: A meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Exp Ther Med (2016) — summary generated from the PubMed abstract.
- 2016
Exp Ther Med17 citations